Harvard Chan School students named 2023 Cheng Fellows

Source

Ivan Hsiao and Collins Oghor

September 13, 2023 – Two students from Harvard T.H. Chan School of Public Health have been selected as 2023 Adrian Cheng Fellows of the New World Social Innovation Fellows Program at Harvard Kennedy School’s Social Innovation and Change Initiative (SICI).

Through teaching, research, and field building efforts, SICI aims to help aspiring and longtime social innovators to navigate the challenges of initiating and implementing positive social change. SICI’s New World Social Innovation Fellows Program selects and supports students—known as Cheng Fellows—to help them address pressing social problems in new and creative ways. The program offers co-curricular programming, coaching, mentoring, and seed funding to help students develop and scale their efforts while in school and after graduation. The 14 fellows in this year’s cohort represent seven schools across Harvard and work in a diverse range of areas, including climate justice, public health, and education.

The two Harvard Chan School Cheng Fellows and their projects are:

Ivan Hsiao, MPH ’24, aims to address health inequities faced by the transgender and nonbinary community by improving access to gender-affirming health care. They are the founder of TransIQ, an online educational course for primary care providers that teaches a comprehensive overview of gender-affirming care based on clinical research and treatment best practices, enabling clinicians to deliver transgender-competent health care.

Collins Oghor, MPH ’24, is the co-founder and CEO of Collogh Cares Inc., a digital health technology and advocacy startup that is committed to preventing kidney failure. The startup has developed a digital health ecosystem and care management service to support kidney specialist clinics in chronic care management and remote monitoring of their highest-risk chronic kidney disease patients. Long-term, the company’s goal is to develop its NephroAI platform—a kidney education platform that uses artificial intelligence—to support patients worldwide, especially in areas with a shortage of specialists.

– Jay Lau